Cargando…

Pharmaceutical Market Access: current state of affairs and key challenges – results of the Market Access Launch Excellence Inventory (MALEI)

OBJECTIVES: To take inventory of the current state of affairs of Market Access Launch Excellence in the life sciences industry. To identify key gaps and challenges for Market Access (MA) and discuss how they can be addressed. To generate a baseline for benchmarking MA launch excellence. METHODOLOGY:...

Descripción completa

Detalles Bibliográficos
Autor principal:	Koch, Marcus A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Routledge 2015
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956289/ https://www.ncbi.nlm.nih.gov/pubmed/29785250 http://dx.doi.org/10.3402/jmahp.v3.29679

Ejemplares similares

The Market Access Society launches a new journal
por: Toumi, Mondher
Publicado: (2013)

Pharmaceutical innovation and access to financial markets
por: Blau, Benjamin M., et al.
Publicado: (2022)

Drug repurposing in pharmaceutical industry and its impact on market access: market access implications
por: Murteira, Susana, et al.
Publicado: (2014)

Pharmaceutical market access in emerging markets: concepts, components, and future
por: Kumar, Anuj, et al.
Publicado: (2014)

Access to Medicines, Access to Markets
por: Sismondo, Sergio
Publicado: (2020)

New drug regulations in France: what are the impacts on market access? Part 2 – impacts on market access and impacts for the pharmaceutical industry
por: Rémuzat, Cécile, et al.
Publicado: (2013)

Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts
por: Jarosławski, Szymon, et al.
Publicado: (2011)

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
por: Badora, Karolina, et al.
Publicado: (2017)

The Role of Marketing in Launching New Products
por: Baker, Phil
Publicado: (2010)

How to Launch Products in Uncertain Markets
por: Ross, Jan-Michael
Publicado: (2018)

Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications
por: Murteira, Susana, et al.
Publicado: (2014)

Changes in launch delay and availability of pharmaceuticals in 30 European markets over the past two decades
por: Büssgen, Melanie, et al.
Publicado: (2022)

Increasing Access to Farmers Markets for Beneficiaries of Nutrition Assistance: Evaluation of the Farmers Market Access Project
por: Cole, Kate, et al.
Publicado: (2013)

Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature
por: Murteira, Susana, et al.
Publicado: (2013)

From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries
por: Panteli, Dimitra, et al.
Publicado: (2015)

Access to and utilization of local digital marketing platforms in potato marketing in Kenya
por: Maina, Florence, et al.
Publicado: (2023)

Challenges constraining access to insulin in the private-sector market of Delhi, India
por: Sharma, Abhishek, et al.
Publicado: (2016)

China's Pharmaceutical Market: Business Environment and Market Dynamics
por: Brueckner, Michael, et al.
Publicado: (2005)

Market access pathways for cell therapies in France
por: Rémuzat, Cécile, et al.
Publicado: (2015)

Cell line access to revolutionize the biosimilars market
por: Gotham, Dzintars
Publicado: (2018)

PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities
por: Thomas, M., et al.
Publicado: (2020)

Perceptions and factors affecting pharmaceutical market access: results from a literature review and survey of stakeholders in different settings
por: Sendyona, Semukaya, et al.
Publicado: (2016)

Patient access schemes in Asia-pacific markets: current experience and future potential
por: Lu, Christine Y, et al.
Publicado: (2015)

Market access after the Uruguay Round : investment, competition, and technology perspectives /
Publicado: (1996)

Peculiarity of Pharmaceutical Marketing in Serbia
por: Dickov, Veselin
Publicado: (2015)

Trends in Iran Pharmaceutical Market
por: Cheraghali, Abdol Majid
Publicado: (2017)

Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe
por: Akhmetov, Ildar, et al.
Publicado: (2015)

Farm production, market access and dietary diversity in Malawi
por: Koppmair, Stefan, et al.
Publicado: (2016)

New, Free and Accessible Web Platform Launched
Publicado: (2009)

Vegan Alternatives to Processed Cheese and Yogurt Launched in the European Market during 2020: A Nutritional Challenge?
por: Boukid, Fatma, et al.
Publicado: (2021)

Integrating Excel and Access
por: Schmalz, Michael
Publicado: (2005)

The Structure of the World Pharmaceutical Market: Prioritizing Iran’s Target Export Markets
por: Shabaninejad, Hosein, et al.
Publicado: (2019)

Digital marketing of nutraceutical and pharmaceutical supplements: marketing ethics and consumer comfort
por: Zoupos, Dimitrios, et al.
Publicado: (2022)

Pharmaceutical Marketing and the Invention of the Medical Consumer
por: Applbaum, Kalman
Publicado: (2006)

The Influence of Emerging Markets on the Pharmaceutical Industry
por: Tannoury, Maya, et al.
Publicado: (2017)

Pharmaceutical nanotechnology: from the bench to the market
por: Mazayen, Zaed M., et al.
Publicado: (2022)

Pharmaceutical marketing: the example of drug samples
por: Alagha, Emily Couvillon, et al.
Publicado: (2022)

Improving the level of food safety and market access in developing countries
por: Wahidin, Dasep, et al.
Publicado: (2018)

Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries
por: Patikorn, Chanthawat, et al.
Publicado: (2022)

NAR launches new Advance Access publication model
por: Saxby, Claire
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_lq0fq0vqfp2br0ov9k7q20rm0v